Your browser doesn't support javascript.
loading
Gut Microbiota Host-Gene Interaction.
Cuomo, Paola; Capparelli, Rosanna; Alifano, Marco; Iannelli, Antonio; Iannelli, Domenico.
Afiliación
  • Cuomo P; Department of Agriculture Sciences, University of Naples "Federico II", Via Università 100, Portici, 80055 Naples, Italy.
  • Capparelli R; Department of Agriculture Sciences, University of Naples "Federico II", Via Università 100, Portici, 80055 Naples, Italy.
  • Alifano M; Thoracic Surgery Department, Cochin Hospital, APHP Centre, University of Paris, 75014 Paris, France.
  • Iannelli A; INSERM, U1138, Team "Cancer, Immune Control, and Escape", Cordeliers Research Center, University of Paris, 75014 Paris, France.
  • Iannelli D; Centre Hospitalier Universitaire de Nice-Digestive Surgery and Liver Transplantation Unit, Archet 2 Hospital, 06202 Nice, France.
Int J Mol Sci ; 23(22)2022 Nov 08.
Article en En | MEDLINE | ID: mdl-36430197
ABSTRACT
Studies carried out in the last ten years have shown that the metabolites made up from the gut microbiota are essential for multiple functions, such as the correct development of the immune system of newborns, interception of pathogens, and nutritional enrichment of the diet. Therefore, it is not surprising that alteration of the gut microbiota is the starting point of gastrointestinal infection, obesity, type 2 diabetes, inflammatory bowel disease, colorectal cancer, and lung cancer. Diet changes and antibiotics are the major factors damaging the gut microbiota. Early exposure of the newborns to antibiotics may prevent their correct development of the immune system, exposing them to pathogen infections, allergies, and chronic inflammatory diseases. We already know much on how host genes, microbiota, and the environment interact, owing to experiments in several model animals, especially in mice; advances in molecular technology; microbiota transplantation; and comparative metagenomic analysis. However, much more remains to be known. Longitudinal studies on patients undergoing to therapy, along with the identification of bacteria prevalent in responding patients may provide valuable data for improving therapies.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Microbiota / Microbioma Gastrointestinal Tipo de estudio: Observational_studies / Prognostic_studies Límite: Animals Idioma: En Revista: Int J Mol Sci Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Microbiota / Microbioma Gastrointestinal Tipo de estudio: Observational_studies / Prognostic_studies Límite: Animals Idioma: En Revista: Int J Mol Sci Año: 2022 Tipo del documento: Article País de afiliación: Italia